Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - desloratadine - tablet - 5mg

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

lupin healthcare (uk - desloratadine - tablet - 5mg

Kanada - angol - Health Canada

apotex inc - desloratadine - tablet - 5mg - desloratadine 5mg - second generation antihistamines

Kanada - angol - Health Canada

dominion pharmacal - desloratadine - tablet - 5mg - desloratadine 5mg - second generation antihistamines

Málta - angol - Medicines Authority

cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - desloratadine - film-coated tablet - desloratadine 5 mg - antihistamines for systemic use

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - desloratadine - oral solution - 500microgram/1ml

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

adiramedica pty ltd - desloratadine, quantity: 0.5 mg/ml - oral liquid, syrup - excipient ingredients: glycerol; propylene glycol; disodium edetate; sunset yellow fcf; sodium benzoate; citric acid monohydrate; sodium citrate; sucrose; purified water; flavour - desloratadine syrup is indicated for: - relief from hayfever, year-round allergies and hives. - relief of symptoms including sneezing, runny or itchy nose, itchy or watery eyes, itchy palate, itchy skin and hives.

Izrael - angol - Ministry of Health

trima israel pharmaceutical products maabarot ltd - desloratadine - syrup - desloratadine 0.5 mg/ml - desloratadine - for the relief of symptoms associated with allergic rhinitis and/or chronic idiopathic urticaria in adults and children 1 year of age and above.

Egyesült Államok - angol - NLM (National Library of Medicine)

bionpharma inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions ( 6.2)]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was

Kenya - angol - Pharmacy and Poisons Board

denk pharma gmbh & co. kg prinzregentenstr. 79 münchen 81675, germany. - desloratadine ph.eur. - film-coated tablet - desloratadine 5 mg, ph.eur. - other antihistamines for systemic use